160 related articles for article (PubMed ID: 25657144)
1. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China.
Liu H; Wang Y; Liu N; Zhao L
Indian J Med Microbiol; 2015 Feb; 33 Suppl():164-5. PubMed ID: 25657144
[No Abstract] [Full Text] [Related]
2. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.
Huang TS; Liu YC; Sy CL; Chen YS; Tu HZ; Chen BC
Antimicrob Agents Chemother; 2008 Jun; 52(6):2226-7. PubMed ID: 18391030
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates.
Prammananan T; Chaiprasert A; Leechawengwongs M
Int J Antimicrob Agents; 2009 Feb; 33(2):190-1. PubMed ID: 18945598
[No Abstract] [Full Text] [Related]
4. In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
Yang C; Lei H; Wang D; Meng X; He J; Tong A; Zhu L; Jiang Y; Dong M
Jpn J Infect Dis; 2012; 65(3):240-2. PubMed ID: 22627306
[TBL] [Abstract][Full Text] [Related]
5. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
[TBL] [Abstract][Full Text] [Related]
6. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
Richter E; Rüsch-Gerdes S; Hillemann D
Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
Yip PC; Kam KM; Lam ET; Chan RC; Yew WW
Int J Antimicrob Agents; 2013 Jul; 42(1):96-7. PubMed ID: 23684005
[No Abstract] [Full Text] [Related]
9. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
Vera-Cabrera L; Castro-Garza J; Rendon A; Ocampo-Candiani J; Welsh O; Choi SH; Blackwood K; Molina-Torres C
Antimicrob Agents Chemother; 2005 Oct; 49(10):4351-3. PubMed ID: 16189119
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
[TBL] [Abstract][Full Text] [Related]
12. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
Cremades R; Rodríguez JC; Garcia-Pachón E; Galiana A; Ruiz-García M; López P; Royo G
APMIS; 2011 Apr; 119(4-5):304-8. PubMed ID: 21492231
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria.
Molicotti P; Ortu S; Bua A; Cannas S; Sechi LA; Zanetti S
New Microbiol; 2006 Oct; 29(4):275-80. PubMed ID: 17201094
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs.
Alcalá L; Ruiz-Serrano MJ; Pérez-Fernández Turégano C; García De Viedma D; Díaz-Infantes M; Marín-Arriaza M; Bouza E
Antimicrob Agents Chemother; 2003 Jan; 47(1):416-7. PubMed ID: 12499228
[TBL] [Abstract][Full Text] [Related]
15. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
[No Abstract] [Full Text] [Related]
16. In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates.
Tato M; de la Pedrosa EG; Cantón R; Gómez-García I; Fortún J; Martín-Davila P; Baquero F; Gomez-Mampaso E
Int J Antimicrob Agents; 2006 Jul; 28(1):75-8. PubMed ID: 16774814
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of linezolid against multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis in Iran.
Kazemian H; Haeili M; Kardan Yamchi J; Rezaei F; Gizaw Feyisa S; Zahednamazi F; Mohajeri P; Zaker Bostanabd S; Hashemi Shahraki A; Imani Fooladi AA; Feizabadi MM
Int J Antimicrob Agents; 2015 Jun; 45(6):668-70. PubMed ID: 25795315
[No Abstract] [Full Text] [Related]
18. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
Nie WJ; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
[No Abstract] [Full Text] [Related]
19. In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis.
Bolhuis MS; van der Laan T; Kosterink JG; van der Werf TS; van Soolingen D; Alffenaar JW
Eur Respir J; 2014 Sep; 44(3):808-11. PubMed ID: 24791826
[No Abstract] [Full Text] [Related]
20. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]